1. PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases
   Hugo Christian Monroy-Ramirez et al, 2021, International Journal of Molecular Sciences CrossRef
2. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway
   Hong-Yuan Wang et al, 2016, Biomedicine & Pharmacotherapy CrossRef
3. The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity
   Saghar Yousefnia et al, 2018, Gene CrossRef
4. An immunogenomic signature for molecular classification in hepatocellular carcinoma
   Weiwei Zhuang et al, 2021, Molecular Therapy - Nucleic Acids CrossRef
5. Combination treatment strategies with a focus on rosiglitazone and adriamycin for insulin resistant liver cancer
   Yi-Fan Dang et al, 2021, Journal of Drug Targeting CrossRef
6. KGCN-DDA: A Knowledge Graph Based GCN Method for Drug-Disease Association Prediction
   Hongyu Kang et al, 2024, Intelligent Computers, Algorithms, and Applications CrossRef
7. Dysregulation of miR484-TUSC5 axis takes part in the progression of hepatocellular carcinoma
   Shanzong Wang et al, 2019, The Journal of Biochemistry CrossRef
8. Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists
   Mohamed A. Abdelgawad et al, 2022, Pharmaceuticals CrossRef
9. FAM3A mediates PPARγ's protection in liver ischemia-reperfusion injury by activating Akt survival pathway and repressing inflammation and oxidative stress
   Zhenzhen Chen et al, 2017, Oncotarget CrossRef
10. Drug Repurposing for Retinoblastoma: Recent Advances
    Kamakshi Dandu et al, 2019, Current Topics in Medicinal Chemistry CrossRef
11. New 4-thiazolidinone-based molecules Les-2769 and Les-3266 as possible PPARγ modulators
    Monika Bar et al, 2022, Bioorganic Chemistry CrossRef
12. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios
    Swati Katoch et al, 2022, World Journal of Gastroenterology CrossRef
13. Research Advances in the Correlation between Peroxisome Proliferator-Activated Receptor-γ and Digestive Cancers
    Shuqi Xu et al, 2018, PPAR Research CrossRef
14. Pioglitazone inhibits growth of human retinoblastoma cells via regulation of NF-κB inflammation signals
    Fengyun Wang et al, 2017, Journal of Receptors and Signal Transduction CrossRef
15. Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms
    Yong Zhang et al, 2017, Science China Life Sciences CrossRef
16. Identification of Crucial Genetic Factors, Such as PPARγ, that Regulate the Pathogenesis of Fatty Liver Disease in Dairy Cows Is Imperative for the Sustainable Development of Dairy Industry
    Kerong Shi et al, 2020, Animals CrossRef
17. Therapeutic targets for metabolic dysfunction-associated steatotic liver disease and their roles in hepatocellular carcinoma
    Chenyu Wei et al, 2023, Exploration of Digestive Diseases CrossRef